Země: Austrálie
Jazyk: angličtina
Zdroj: Department of Health (Therapeutic Goods Administration)
phenol, Quantity: 250 mg
Phebra Pty Ltd
Phenol
Injection, solution
Excipient Ingredients: Almond oil
Submucosal
5x250mg/5mL
(S4) Prescription Only Medicine
Haemorol is indicated for the treatment of symptomatic haemorrhoids in patients with an inadequate response to conservative therapy such as dietary manipulation. It must only be injected submucosally and its use is usually confined to first degree or second degree haemorrhoids.
Visual Identification: a clear, yellowish solution, free from visible particles; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius
Licence status A
2009-09-04
Haemorol (Oily Phenol Injection) Page 1 of 3 _Version 05-1 _ HAEMOROL™ OILY PHENOL INJECTION (PHENOL) EACH 5 ML CONTAINS PHENOL 250 MG IN ALMOND OIL _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Haemorol. It does not contain all the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits . Your doctor has weighed the risks of you being given Haemorol against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR. KEEP THIS LEAFLET . You may need to read it again. WHAT HAEMOROL IS USED FOR Haemorol is used to treat haemorrhoids when other methods of treatment, such as changes in diet, have not worked. Haemorrhoids occur when small veins near the anus become swollen. Haemorol works by attaching the veins to the tissue around them, preventing them from swelling. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT THIS MEDICINE WHICH HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. BEFORE YOU ARE GIVEN HAEMOROL _WHEN YOU MUST NOT BE GIVEN _ _IT _ Y OU SHOULD NOT BE GIVEN HAEMOROL IF YOU HAVE AN ALLERGY TO ANY MEDICINE CONTAINING PHENOL OR ALMOND OIL. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. THIS MEDICINE SHOULD NOT BE GIVEN TO INFANTS OR CHILDREN. Safety in infants and children has not been established. YOU SHOULD NOT BE GIVEN THIS MEDICINE IF THE SOLUTION IS DISCOLOURED, CLOUDY, TURBID, OR A PRECIPITATE OR PARTICLES ARE PRESENT. The solution is normally clear, yellowish and viscous. YOU SHOULD NOT BE GIVEN THIS MEDICINE AFTER THE EXPIRY DATE PRINTED ON THE PACK, OR IF THE PACKAGING IS TORN OR SHOWS SIGNS OF TAMPERING. If you are given this medicine after the expiry date has passed, it may not work as well. IF YOU ARE NOT Přečtěte si celý dokument
PRODUCT INFORMATION Australian Product Information – Haemorol Oily Phenol Injection Page 1 of 8 Version 05-1 HAEMOROL™ OILY PHENOL INJECTION (PHENOL) 1 NAME OF THE MEDICINE Phenol 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Haemorol is a solution containing 250 mg phenol in almond oil to 5 mL (phenol 5% w/v). Excipients of known effect: tree nuts. For the full list of excipients, see Section 6.1 List of Excipients. 3 PHARMACEUTICAL FORM Haemorol is a clear, yellowish solution, free from visible particles. 4 CLINICAL PARTICULARS 4.1 T HERAPEUTIC INDICATIONS Haemorol is indicated for the treatment of symptomatic haemorrhoids in patients with an inadequate response to conservative therapy such as dietary manipulation. It must only be injected submucosally and its use is usually confined to first degree or second degree haemorrhoids. 4.2 D OSE AND METHOD OF ADMINISTRATION Haemorol is for submucosal injection only (i.e. local administration); personnel administering this treatment should be trained in the correct placement of submucosal injections. Haemorol is not to be administered intrathecally, or injected into a blood vessel or into deep tissues (see Section 4.4 Special Warnings and Precautions for Use). Haemorol is administered by submucosal injection of 2 to 5 mL. It may be injected into the submucosal space above each of the three principle haemorrhoids. The total maximum volume that may be injected in any one treatment is 10 mL. It is preferable that only sterile glass syringes be used for injecting this product, to minimise the possibility of absorption or extraction from plastic syringe components. However, plastic syringes with needles with plastic hubs may be used if the injection is to be administered immediately. 4.3 C ONTRAINDICATIONS Haemorol is contraindicated in patients hypersensitive to phenol or almond oil, in neonates and children (see Section 4.4 Special Warnings and Precautions for Use), and for use over large areas, since sufficient amounts may be absorbed to give rise to toxic symptoms. 4. Přečtěte si celý dokument